The fluid study protocol: A randomized controlled study on the effects of bioimpedance analysis and vitamin D on left ventricular mass in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 31, Issue 5, 2011, Pages 529-536

  Su, Winnie S ^a   Gangji, Azim S ^a   Margetts, Peter M ^a   Bosch, Jackie ^b   Yusuf, Salim ^a,b   Clase, Catherine M ^a   Ganame, Javier ^a   Noseworthy, Michael ^c   Lonn, Eva ^a,b   Jain, Arsh K ^d   McCormick, Brendan ^e   Brimble, K Scott ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Bioimpedance; Cardiovascular disease; Hypervolemia; Left ventricular hypertrophy; Randomized controlled trial; Vitamin D

Indexed keywords

BIOLOGICAL MARKER; CALCITRIOL; COLECALCIFEROL; PLACEBO; VITAMIN D RECEPTOR;

ADULT; ARTICLE; BIOIMPEDANCE ANALYSIS GUIDED FLUID MANAGEMENT; BLOOD PRESSURE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HEART DEATH; HEART LEFT VENTRICLE MASS; HEART VENTRICLE VOLUME; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMPEDANCE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANE TRANSPORT; MULTICENTER STUDY; OUTCOME ASSESSMENT; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; WALKING;

EID: 84856205137     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2010.00232     Document Type: Article

References (36)

1. Foley RN, Parfrey PS. Cardiovascular disease and mortality in ESRD. J Nephrol 1998; 11:239-45.
2. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360:1395-407.
3. Paniagua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am soc Nephrol 2002; 13:1307-20.
4. Jamal SA, Fitchett D, Lok CE, Mendelssohn DC, Tsuyuki RT. The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis. Nephrol Dial Transplant 2009; 24:3168-74.
5. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, et al. A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 2009; 361:2019-32.
6. Chang TI, Friedman GD, Cheung AK, Greene T, Desai M, Chertow GM. Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. J Hum Hypertens 2011; 25:98-105.
7. Fein P, Chattopadhyay J, Paluch MM, Borawski C, Matza B, Avram MM. Enrollment fluid status is independently associated with long-term survival of peritoneal dialysis patients. Adv Perit Dial 2008; 24:79-83.
8. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial transplant 2001; 16:2207-13.
9. Middleton RJ, Parfrey PS, Foley RN. Left ventricular hypertrophy in the renal patient. J Am soc Nephrol 2001; 12:1079-84.
10. Zoccali C, Benedetto FA, Mallamaci F, Tripepi G, Giacone G, Cataliotti A, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am soc Nephrol 2001; 12:2768-74.
11. Silberberg JS, Barré PE, Prichard SS, Sniderman AD. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int 1989; 36:286-90.
12. Stack AG, Saran R. Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States. Am J Kidney Dis 2002; 40:1202-10.
13. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-6.
14. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004; 292:2350-6.
15. Foley RN, Parfrey PS, Kent GM, Harnett JD, Murray DC, Barré PE. Serial change in echocardiographic parameters and cardiac failure in end-stage renal disease. J Am Soc Nephrol 2000; 11:912-16.
16. London GM, Pannier B, Guerin AP, Blacher J, Marchais SJ, Darne B, et al. Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study. J Am soc Nephrol 2001; 12:2759-67.
17. Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3:153-8.
18. Piccoli A on behalf of the Italian CAPD-BIA Study Group. Bioelectric impedance vector distribution in peritoneal dialysis patients with different hydration status. Kidney Int 2004; 65:1050-63.
19. Nescolarde L, Piccoli A, Román A, Núñez A, Morales R, Tamayo J, et al. Bioelectrical impedance vector analysis in haemodialysis patients: relation between oedema and mortality. Physiol Meas 2004; 25:1271-80.
20. Wilkieson TJ, Ranganath N, Robinson KR, Prieur AJ, Rabbat CG, Gangji AS, et al. Reliability of bioimpedance methods in dialysis patients (Abstract). J Am soc Nephrol 2009; 20:140A.
21. Davies SJ, Woodrow G, Donovan K, Plum J, Williams P, Johansson AC, et al. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14:2338-44.
22. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, van den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
23. Paniagua R, Orihuela O, Ventura MD, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, et al. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis. Kidney Int Suppl 2008; (108):S125-30.
24. Sav T, Oymak O, Inanc MT, Dogan A, Tokgoz B, Utas C. Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int 2009; 29:443-9.
25. Lewin E, Olgaard K. When is vitaminD contraindicated in dialysis patients? Semin Dial 2009; 22:240-2.
26. 3. Semin Dial 2007; 20:316-24.
27. Shah N, Bernardini J, Piraino B. Prevalence and correction of 25(OH) vitaminD deficiency in peritoneal dialysis patients. Perit Dial Int 2005; 25:362-6.
28. Wang AY, Lam CW, Sanderson JE, Wang M, Chan IH, Lui SF, et al. Serum 25-hydroxyvitaminD status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study. Am J Clin Nutr 2008; 87:1631-8.
29. Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF. Meta-analysis: vitaminD compounds in chronic kidney disease. Ann Intern Med 2007; 147:840-53.
30. 2) in stage5 chronic kidney disease patients. J Ren Nutr 2008; 18:375-82.
31. Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J Clin endocrinol Metab 2008; 93:3927-35.
32. Matias PJ, Jorge C, Ferreira C, Borges M, Aires I, Amaral T, et al. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin J Am soc Nephrol 2010; 5:905-11.
33. Grothues F, Smith GC, Moon JC, Bellenger NG, Collins P, Klein HU, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002; 90:29-34.
34. Culleton BF, Walsh M, Klarenbach SW, Mortis G, Scott-Douglas N, Quinn RR, et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA 2007; 298:1291-9.
35. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barré PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial transplant 1996; 11:1277-85.
36. Stewart GA, Mark PB, Johnston N, Foster JE, Cowan M, Rodger RS, et al. Determinants of hypertension and left ventricular function in end stage renal failure: a pilot study using cardiovascular magnetic resonance imaging. Clin Physiol Funct Imaging 2004; 24:387-93.